| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CCDC66_0013000 | Exon-Exon | chr3:56650496-56650716 | chr3:56616468-56616688 | 221 nt | 0.3303 |
| hsa_CCDC66_0013100 | Exon-Exon | chr3:56651140-56653929 | chr3:56617112-56619901 | 166 nt | 0.4217 |
| hsa_CCDC66_0013200 | Exon-Exon | chr3:56651558-56652240 | chr3:56617530-56618212 | 117 nt | 0.3846 |
| hsa_CCDC66_0013300 | Exon-Exon | chr3:56651615-56652394 | chr3:56617587-56618366 | 214 nt | 0.4065 |
| hsa_CCDC66_0013400 | Exon-Exon | chr3:56652200-56653555 | chr3:56618172-56619527 | 298 nt | 0.3893 |
| hsa_CCDC66_0013500 | Exon-Exon | chr3:56652200-56653929 | chr3:56618172-56619901 | 166 nt | 0.4217 |
| hsa_CCDC66_0013600 | Exon-Exon | chr3:56652836-56653298 | chr3:56618808-56619270 | 463 nt | 0.4428 |
| hsa_CCDC66_0013700 | Exon-Exon | chr3:56653299-56653929 | chr3:56619271-56619901 | 257 nt | 0.3891 |
| hsa_CCDC66_0014100 | Exon-Exon | chr3:56653531-56653929 | chr3:56619503-56619901 | 25 nt | 0.4400 |
| hsa_CCDC66_0014200 | Intron-Intron | chr3:56654033-56654826 | chr3:56620005-56620798 | 794 nt | 0.3489 |
A study in human lung adenocarcinoma cells demonstrated that the circCCDC66 increases epithelial-mesenchymal transition and drug resistance [Huang et al. DOI:10.3390/cells11091381].